ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,692Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 107

$722K Total Retail Price of All Prescriptions

Rank: 19 out of 107

478 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 478 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

18% of this provider’s 478 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 16,126 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
POTASSIUM CHLORIDE 956 955 1 18
BUMETANIDE 950 935 10 2 77
METOPROLOL TARTRATE 839 812 3 7
LEVOTHYROXINE SODIUM 814 797 4 1
OMEPRAZOLE 633 614 5 6
CITALOPRAM HBR 622 622 6 9
AMLODIPINE BESYLATE 600 587 7 5
HYDROCODONE-ACETAMINOPHEN 519 506 S3 8 20
RISPERIDONE 405 388 9 26
ISOSORBIDE MONONITRATE ER 362 362 10 30
WARFARIN SODIUM 329 221 11 8
DONEPEZIL HCL 263 263 12 10
CLOPIDOGREL 260 252 13 29
POLYETHYLENE GLYCOL 3350 251 250 14 24
PANTOPRAZOLE SODIUM 207 201 15 28
METOPROLOL SUCCINATE 186 182 16 15
NOVOLIN 70-30 185 185 17 125
PLAVIX 154 152 18 43
DIOVAN 152 130 19 33
DIGOXIN 149 149 20 37
HYDROCHLOROTHIAZIDE 144 137 21 14
DIOVAN HCT 138 134 22 137
LISINOPRIL 130 111 23 4
SIMVASTATIN 128 124 24 2
PREDNISONE 120 120 25 39
ATORVASTATIN CALCIUM 111 94 26 17
TAMSULOSIN HCL 110 98 27 27
TRAMADOL HCL 108 107 28 23
NAMENDA 102 93 29 19
FUROSEMIDE 97 97 30 3
GLIPIZIDE XL 97 93 30 194
FENTANYL 96 95 S2 32 50
HUMULIN 70-30 95 92 33 247
CIPROFLOXACIN HCL 94 92 34 73
ATENOLOL 90 89 35 21
MONOJECT INSULIN SYRINGE 87 82 36 272
METFORMIN HCL 87 87 36 13
PREMARIN 86 86 R 38 327
TRAZODONE HCL 84 74 39 22
OLANZAPINE 82 74 40 57
SERTRALINE HCL 82 63 40 12
ALBUTEROL SULFATE 82 82 40 67
LOSARTAN POTASSIUM 79 79 43 36
MUPIROCIN 76 68 44 251
CARVEDILOL 76 76 44 25
AZITHROMYCIN 76 76 44 87
GABAPENTIN 75 75 47 11
ALENDRONATE SODIUM 74 74 48 35
LABETALOL HCL 71 71 49 275
QUETIAPINE FUMARATE 70 70 50 31
DILTIAZEM 24HR CD 70 70 50 89
MORPHINE SULFATE ER 69 69 S2 52 115
NEXIUM 69 69 52 61
DILTIAZEM 24HR ER 69 69 52 158
MIRTAZAPINE 68 68 55 16
MELOXICAM 67 67 56 135
RAMIPRIL 64 64 57 134
OXYCONTIN 62 62 S2 58 124
TROSPIUM CHLORIDE 61 61 59 363
DILTIAZEM ER 60 60 60 291
ZOLPIDEM TARTRATE 58 58 61 38
KLOR-CON 10 57 54 62 259
HYDRALAZINE HCL 57 57 62 58
FLUTICASONE PROPIONATE 55 55 64 54
OLANZAPINE ODT 54 53 65 298
AVODART 54 54 65 248
AMITRIPTYLINE HCL 53 53 R 67 224
MINOXIDIL 53 53 67 385
DIVALPROEX SODIUM 52 43 69 55
CEFUROXIME 52 51 69 265
SINGULAIR 51 51 71 127
INSULIN SYRINGE 50 47 72 162
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.